Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Molloy

Showing results (51-60 of 70) with videos related to

Pageof 7
Sort By:
Open Forum Infectious Diseases|October 14, 2021
Short-term Mortality Outcomes of HIV-Associated Cryptococcal Meningitis in Antiretroviral Therapy-Naïve and -Experienced Patients in Sub-Saharan AfricaNewton Kalata, Jayne Ellis, Cecilia Kanyama, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 1, 2019
Addition of Flucytosine to Fluconazole for the Treatment of Cryptococcal Meningitis in Africa: A Multicountry Cost-effectiveness AnalysisTinevimbo Shiri, Angela Loyse, Lawrence Mwenge, et al.
Trials|June 18, 2015
AMBITION-cm: intermittent high dose AmBisome on a high dose fluconazole backbone for cryptococcal meningitis induction therapy in sub-Saharan Africa: study protocol for a randomized controlled trialMooketsi Molefi, Awilly A Chofle, Síle F Molloy, et al.
Plos Neglected Tropical Diseases|June 30, 2017
Cryptococcal meningitis: A neglected NTD?Síle F Molloy, Tom Chiller, Gregory S Greene, et al.
Open Forum Infectious Diseases|May 3, 2021
Fungal Burden and Raised Intracranial Pressure Are Independently Associated With Visual Loss in Human Immunodeficiency Virus-Associated Cryptococcal MeningitisSíle F Molloy, Brad Ross, Cecilia Kanyama, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 3, 2025
Recent Antiretroviral Therapy Initiation Is Associated With Increased Mortality Risk in HIV-associated Cryptococcal Meningitis: An Analysis of Clinical Trial Data From AfricaMelanie Moyo, David S Lawrence, James Jafali, et al.
The Lancet. Global Health|January 31, 2025
Causes of HIV-related CNS infection in Cameroon, Malawi, and Tanzania: epidemiological findings from the DREAMM HIV-related CNS implementation studyCecilia Kanyama, Charles Kouanfack, Saulos Nyirenda, et al.
Trials|March 25, 2026
Fluconazole plus flucytosine versus fluconazole alone for adults with HIV-associated cryptococcal antigenaemia identified through screening: a multi-centre phase III randomised-controlled trialKyla Murphy, Jeremy S Nel, Mahomed-Yunus Moosa, et al.
The Lancet. Global Health|April 27, 2025
Personalised risk-prediction tools for cryptococcal meningitis mortality to guide treatment stratification in sub-Saharan Africa: a prognostic modelling study based on pooled analysis of two randomised controlled trialsThomas H A Samuels, Sile F Molloy, David S Lawrence, et al.
The Lancet. HIV|October 6, 2023
Reduction in mortality from HIV-related CNS infections in routine care in Africa (DREAMM): a before-and-after, implementation studySayoki Mfinanga, Cecilia Kanyama, Charles Kouanfack, et al.
Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Open Forum Infectious Diseases|October 14, 2021
Short-term Mortality Outcomes of HIV-Associated Cryptococcal Meningitis in Antiretroviral Therapy-Naïve and -Experienced Patients in Sub-Saharan AfricaNewton Kalata, Jayne Ellis, Cecilia Kanyama, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 1, 2019
Addition of Flucytosine to Fluconazole for the Treatment of Cryptococcal Meningitis in Africa: A Multicountry Cost-effectiveness AnalysisTinevimbo Shiri, Angela Loyse, Lawrence Mwenge, et al.
Trials|June 18, 2015
AMBITION-cm: intermittent high dose AmBisome on a high dose fluconazole backbone for cryptococcal meningitis induction therapy in sub-Saharan Africa: study protocol for a randomized controlled trialMooketsi Molefi, Awilly A Chofle, Síle F Molloy, et al.
Plos Neglected Tropical Diseases|June 30, 2017
Cryptococcal meningitis: A neglected NTD?Síle F Molloy, Tom Chiller, Gregory S Greene, et al.
Open Forum Infectious Diseases|May 3, 2021
Fungal Burden and Raised Intracranial Pressure Are Independently Associated With Visual Loss in Human Immunodeficiency Virus-Associated Cryptococcal MeningitisSíle F Molloy, Brad Ross, Cecilia Kanyama, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 3, 2025
Recent Antiretroviral Therapy Initiation Is Associated With Increased Mortality Risk in HIV-associated Cryptococcal Meningitis: An Analysis of Clinical Trial Data From AfricaMelanie Moyo, David S Lawrence, James Jafali, et al.
The Lancet. Global Health|January 31, 2025
Causes of HIV-related CNS infection in Cameroon, Malawi, and Tanzania: epidemiological findings from the DREAMM HIV-related CNS implementation studyCecilia Kanyama, Charles Kouanfack, Saulos Nyirenda, et al.
Trials|March 25, 2026
Fluconazole plus flucytosine versus fluconazole alone for adults with HIV-associated cryptococcal antigenaemia identified through screening: a multi-centre phase III randomised-controlled trialKyla Murphy, Jeremy S Nel, Mahomed-Yunus Moosa, et al.
The Lancet. Global Health|April 27, 2025
Personalised risk-prediction tools for cryptococcal meningitis mortality to guide treatment stratification in sub-Saharan Africa: a prognostic modelling study based on pooled analysis of two randomised controlled trialsThomas H A Samuels, Sile F Molloy, David S Lawrence, et al.
The Lancet. HIV|October 6, 2023
Reduction in mortality from HIV-related CNS infections in routine care in Africa (DREAMM): a before-and-after, implementation studySayoki Mfinanga, Cecilia Kanyama, Charles Kouanfack, et al.
Pageof 7